Non-Dilutive Funding in Europe: Grants, Tax Incentives and Loans for Startups (2026)

Non-dilutive funding is money that finances your company without costing you shares. In Europe it comes in three forms: grants from EU and national programmes, tax incentives for research and development (R&D), and subsidised loans. Each runs on a different clock and comes with different conditions.

This guide shows what startups can get in 2026 and when the cash actually reaches your account. It also flags where well-known programmes involve equity after all. Germany serves as the national example, because that is where Be-Funded works.

What is non-dilutive funding?

Non-dilutive funding is capital a company receives without issuing new shares, so every existing shareholder keeps the same percentage of the business. It comes as grants, tax incentives or loans. Venture capital works the other way: investors receive new shares, and your stake shrinks with every round.

How the three families differ:

• Grants are non-repayable. You compete for them, spend them on agreed costs and report on how you used them.
• Tax incentives refund part of costs you have already incurred. In Germany the research allowance for startups and SMEs is a legal entitlement, with no competition for places.
• Loans must be repaid, but the lender takes no ownership.

Every euro of development cost covered this way is a euro you do not have to raise at today's valuation. For a pre-revenue team, that can decide whether the next round is negotiated from strength or out of necessity. The price is time. Grants take months to decide, and tax incentives pay only after the costs are on your books.

Startup funding in Europe: which non-dilutive options exist in 2026?

Startups in Europe can combine EU grants, national grants and stipends, R&D tax incentives and promotional-bank loans, meaning subsidised loans from public development banks. According to a June 2026 release by the Organisation for Economic Co-operation and Development (OECD), 34 of 38 OECD countries offered R&D tax relief in 2025. Costa Rica, Israel, Latvia and Luxembourg were the only exceptions.

The table compares the instruments a Germany-based startup is most likely to use. Official sources for these figures are linked in this article.

One German programme is missing on purpose: ZIM (Zentrales Innovationsprogramm Mittelstand), the federal R&D grant programme for SMEs. The Federal Ministry for Economic Affairs and Energy (BMWE) has accepted no new ZIM applications since 7 July 2026, except for projects in open international calls. The ministry aims to reopen it in early 2027, subject to the 2027 federal budget. If your 2026 project plan relied on the ZIM grant, you need a different instrument now.

The right option depends on whether you apply alone or with partners and whether your company exists yet. How close your technology is to market matters too. A university team before founding looks at the EXIST founder stipend, and a company with a partner abroad looks at Eurostars. Almost every company doing genuine R&D in Germany should check the Forschungszulage first, because it does not depend on winning a competition.

Which EU grants fund startups, and which parts are really non-dilutive?

The European Innovation Council (EIC) Accelerator, Eurostars and Horizon Europe are the three EU instruments most relevant to startups. Only the EIC Accelerator pairs its grant with an equity investment that dilutes. Eurostars and Horizon Europe pay grants only, but both normally require partners in other countries.

EIC Accelerator: read the equity terms

The EIC Accelerator funds single startups and SMEs developing breakthrough technology, with no consortium required. The 2026 EIC work programme gives it a budget of €634 million and caps each grant below €2.5 million.

The grant is non-dilutive. According to the EIC's February 2026 announcement, the EIC Fund investment offered alongside it, €0.5 million to €10 million per company, is equity; under the EIC Work Programme 2026 the minimum rises to €1 million. In that round the EIC selected 61 companies out of 121 interviewed, and 85% of them received blended finance, meaning grant plus equity. Grant-only awards also exist, so decide before you apply how much of your company you are willing to sell.

Ekaterina Zaharieva, European Commissioner for Startups, Research and Innovation, said in June 2026: "The European Innovation Council was built to take risks." For applicants, that means showing the technical risk plainly instead of playing it down.

Eurostars: the practical entry point for German SMEs

Eureka Eurostars funds cross-border R&D projects led by innovative SMEs, and each country funds its own partners. The Federal Ministry for Research, Technology and Space (BMFTR) pays German SMEs up to 50% of eligible costs. According to the Eureka Network's page for the September 2026 call, that funding is capped at €500,000 for all German partners in a project.

Two further German rules matter. Only R&D up to Technology Readiness Level (TRL) 6 qualifies, TRL being the standard scale of technical maturity. Large German companies must fund their own share.

Eureka's international rules for that call, which closed on 10 September 2026, require:

• a consortium led by an innovative SME from a Eurostars country
• at least two independent partners from at least two Eurostars countries, one of them in the EU or a Horizon Europe associated country
• SMEs carrying at least half of the total project cost, excluding subcontracting
• no single partner or country above 70% of the budget
• a duration of 36 months or less, for civil applications only

Horizon Europe: joining a consortium

Horizon Europe is the EU's research and innovation framework programme. After the EU's mid-term budget review it has an indicative budget of €93.5 billion for 2021 to 2027, according to the European Commission. A startup typically takes part as one partner in an international consortium. For a side-by-side view of the main schemes, see our overview of EU funding programmes for companies.

Why is the Forschungszulage the most predictable non-dilutive funding for startups in Germany?

The Forschungszulage is Germany's research allowance: a tax incentive under the Forschungszulagengesetz (FZulG) that any company taxable in Germany can claim for eligible R&D, with no call deadline and no jury. It is a legal entitlement: if your project meets the criteria, you receive the allowance.

According to the Bescheinigungsstelle Forschungszulage (BSFZ), the body that certifies projects, the rate is 25% of eligible costs, or 35% for small and medium-sized enterprises (SMEs). From 2026 that puts the SME maximum at €4.2 million a year. The FZulG caps the assessment basis at €12 million a year for costs incurred from 2026, the assessment basis being the eligible costs the rate is applied to.

Under the EU definition the BSFZ applies, an SME has fewer than 250 employees. It also needs either turnover of up to €50 million or a balance sheet of up to €43 million, and partner and linked companies count towards those limits. Projects that started after 31 December 2025 also get a 20% flat rate for overheads and operating costs, according to the BSFZ.

How the Forschungszulage pays out

The Federal Ministry of Finance (BMF) describes three steps:

1. Have the BSFZ certify that your project counts as R&D.
2. Claim the allowance from your tax office after your financial year ends.
3. Receive it through your next income or corporate tax assessment: the tax office offsets it, and any surplus is paid out as a tax refund.

The third step is why the allowance works for loss-making startups: with no tax to offset, the full amount is paid out. The Forschungszulage is also widely used. Between September 2020 and June 2026, 26,042 companies filed at least one BSFZ application, covering 63,718 projects, according to the BSFZ's own statistics.

Example: €1.75 million for an AI company

An AI company building explainable, privacy-compliant document analysis claimed the Forschungszulage with Be-Funded on an eligible base of about €5 million. All of that base was in-house personnel work, with no contract research. The allowance came to €1.75 million, and presentation decided the case:

• novelty was argued against the state of the art at project start
• staff hours were assigned year by year
• the application described methods and metrics instead of marketing claims

The full story is in our case study on the research allowance for an AI startup.

Be-Funded runs the Forschungszulage claim from the first eligibility check to the tax-office payout. We write the technical dossier the BSFZ expects, covering novelty, technical risk and method. We then prepare the annual claim so each eligible cost lands in the right financial year at the right rate.

Your engineers spend roughly 6 to 12 hours in interviews; we handle the rest. Fees are success-based and invoiced only after the allowance is paid out. If you are unsure whether your development qualifies, our research allowance consulting team checks it free of charge.

When does a loan count as non-dilutive funding?

A loan counts as non-dilutive funding because the lender takes no shares, but unlike a grant or a tax incentive it must be repaid with interest. In Germany, KfW's ERP-Gründerkredit StartGeld lends up to €200,000 to small companies in their first five years, according to KfW's February 2026 StartGeld page. No more than €80,000 of it may be used for working capital.

KfW, the federal promotional bank, makes the loan for investment and working capital. It offers up to two repayment-free years and does not require you to put in your own capital.

A loan suits costs that grants and the Forschungszulage cover poorly, such as equipment, stock or working capital. It also adds instalments to your cash plan, so model the first repayment date before you sign. How loans fit alongside equity and grants is covered in our guide to startup financing options in Germany.

How do you stack grants, tax incentives and loans without double funding?

You can combine grants, tax incentives and loans in one company, provided each euro of cost is funded by only one instrument. In our practice, that single rule decides whether a combination survives an audit. Keep a simple cost matrix that shows which instrument pays for which cost line.

A workable sequence for a research-based startup often looks like this:

1. Apply for EXIST while the team is still at the university.
2. Claim the Forschungszulage on in-house R&D from the first year of trading.
3. Target Eurostars or the EIC Accelerator once there is a prototype and, for Eurostars, a partner abroad.

Timing matters as much as amount. The dates below come from each programme's own announcements.

The Forschungszulage for this year's costs arrives next year at the earliest. Plan that gap in your runway with equity or a loan.

Why do funding applications get rejected?

Most of the rejections we see come from presentation and paperwork rather than from the technology itself. The five mistakes below come up most often, and each is avoidable if you document as you go instead of reconstructing a year of work at claim time.

• routine development, such as maintenance or customising, presented as R&D
• time records too thin to prove who worked on the project and when
• project descriptions that stay vague about the technical uncertainty
• novelty argued against today's state of the art instead of the state at project start
• the same cost claimed under two instruments

This article is general information, not legal, tax or financial advice. Programme rules change, so check the official sources or speak to an adviser before you apply.